Eiger Mountains
Form DEF 14A
EIGER BIOPHARMACEUTICALS, INC. filed this Form DEF 14A on 04/26/2018
Document Outline
Entire Document (622.1 KB)
Subdocument 1 - DEF 14A - DEFINITIVE PROXY STATEMENT
Page 1 - SCHEDULE 14A INFORMATION
Page 2 - NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
Page 3 - PROXY STATEMENT
Page 4 - What am I voting on?
Page 5 - How many votes do I have?
Page 6 - Beneficial Owner: Shares Registered in the Name of Broker or Bank
Page 7 - How does the Board of Directors recommend that I vote?
Page 8 - N/A
Page 9 - PROPOSAL 1
Page 10 - Eldon Mayer.
Page 11 - CLASS I DIRECTORS
Page 12 - BOARD LEADERSHIP STRUCTURE
Page 13 - Audit Committee
Page 14 - Report of the Audit Committee of the Board of Directors
Page 15 - Compensation Committee Processes and Procedures
Page 16 - Compensation Committee Interlocks and Insider Participation
Page 17 - STOCKHOLDER COMMUNICATIONS WITH THE BOARD OF DIRECTORS
Page 18 - CODE OF ETHICS
Page 19 - PROPOSAL 2
Page 20 - Other Auditors
Page 21 - THE BOARD OF DIRECTORS RECOMMENDS
Page 22 - EXECUTIVE OFFICERS
Page 23 - SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
Page 24 - N/A
Page 25 - SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE
Page 26 - EXECUTIVE COMPENSATION
Page 27 - Outstanding Equity Awards at Fiscal Year-End
Page 28 - Potential Payments upon Termination of Employment or Change in Control with our Current Named Execut
Page 29 - Nonqualified Deferred Compensation
Page 30 - N/A
Page 31 - TRANSACTIONS WITH RELATED PERSONS
Page 32 - Eiger Subscription Agreement
Page 33 - HOUSEHOLDING OF PROXY MATERIALS
Page 34 - OTHER MATTERS
Page 35 - N/A
Page 36 - N/A